APA (7th ed.) Citation

Cascinu, S., Scartozzi, M., Labianca, R., Catalano, V., Silva, R. R., Barni, S., . . . Franciosi, V. (2004). High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer, 90(8), 1521. https://doi.org/10.1038/sj.bjc.6601752

Chicago Style (17th ed.) Citation

Cascinu, S., et al. "High Curative Resection Rate with Weekly Cisplatin, 5-fluorouracil, Epidoxorubicin, 6S-leucovorin, Glutathione, and Filgastrim in Patients with Locally Advanced, Unresectable Gastric Cancer: A Report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)." British Journal of Cancer 90, no. 8 (2004): 1521. https://doi.org/10.1038/sj.bjc.6601752.

MLA (9th ed.) Citation

Cascinu, S., et al. "High Curative Resection Rate with Weekly Cisplatin, 5-fluorouracil, Epidoxorubicin, 6S-leucovorin, Glutathione, and Filgastrim in Patients with Locally Advanced, Unresectable Gastric Cancer: A Report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)." British Journal of Cancer, vol. 90, no. 8, 2004, p. 1521, https://doi.org/10.1038/sj.bjc.6601752.